First Time Loading...

biOasis Technologies Inc
XTSX:BTI

Watchlist Manager
biOasis Technologies Inc Logo
biOasis Technologies Inc
XTSX:BTI
Watchlist
Price: 0.01 CAD Market Closed
Updated: May 5, 2024

biOasis Technologies Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

biOasis Technologies Inc
Revenue Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
biOasis Technologies Inc
XTSX:BTI
Revenue
CA$269.4k
CAGR 3-Years
-33%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%

See Also

What is biOasis Technologies Inc's Revenue?
Revenue
269.4k CAD

Based on the financial report for Nov 30, 2022, biOasis Technologies Inc's Revenue amounts to 269.4k CAD.

What is biOasis Technologies Inc's Revenue growth rate?
Revenue CAGR 5Y
-15%

Over the last year, the Revenue growth was 614%. The average annual Revenue growth rates for biOasis Technologies Inc have been -33% over the past three years , -15% over the past five years .